Stay updated on Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing v3.5.3, indicating a small backend/site update without changes to the study content.
    Difference
    0.1%
    Check dated 2026-05-14T23:13:34.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision tag updated to v3.5.3 (replacing v3.5.2), and certain related topics entries, including Prostate cancer and MedlinePlus Genetics, were removed from the related topics list.
    Difference
    0.2%
    Check dated 2026-04-30T14:55:37.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:53:46.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:42:23.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:57:31.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    - Removed the topic tags 'Prostate cancer' and the related topic 'MedlinePlus Genetics' from the study's metadata.
    Difference
    0.2%
    Check dated 2026-03-04T12:32:40.000Z thumbnail image

Stay in the know with updates to Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.